Attovia Therapeutics, Inc. (ATTO) Insider Trading
Sector: N/A · Market Cap: $1.0B · 0 insider purchases in the last 7 days
No open market insider purchases at Attovia Therapeutics, Inc. in the last 7 days.
Want more?
Sign up free to see 30+ days of history, set alerts, and track ATTO on your watchlist.
Start for FreeAbout Attovia Therapeutics, Inc. Insider Trading
2 insiders at Attovia Therapeutics, Inc. (ATTO) have purchased stock in the past 90 days, totaling $11.6M across 2 transactions (682,352 shares).
The most recent purchase was by 10%+ Owner Sanofi on August 6, 2026 — a $5.1M buy of 300,000 shares at $17.00, bringing his total holdings to 1,082,855 shares.
Insiders who purchased: venBio Global Strategic Fund IV, L.P. (10%+ Owner, 1 buy totaling $6.5M); Sanofi (10%+ Owner, 1 buy totaling $5.1M).
This insider buying is notable given that ATTO had no recorded open market purchases in the nine months before that.
ATTO is in the N/A sector within the N/A industry with a market cap of $1.0B.
Track ATTO insider trading activity, set up email alerts, and get AI-powered trade analysis with a free Insider Trading Tracker account.
More Insider Trading in N/A
NEW GERMANY FUND INC
90 purchases (7d)
GAMGENERAL AMERICAN INVESTORS CO INC
43 purchases (7d)
MXFMEXICO FUND INC
79 purchases (7d)
FINSAngel Oak Financial Strategies Income Term Trust
15 purchases (7d)
ARDCAres Dynamic Credit Allocation Fund, Inc.
2 purchases (7d)
GRXGabelli Healthcare & WellnessRx Trust
33 purchases (7d)